Começar
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

Sem negociações
Veja nos Supergráficos
Visão geralFinançasNotíciasIdeiasMindsSinais técnicosSazonaisTítulos

Títulos

Abaixo está a lista de títulos corporativos AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo
YTM %
Volume
Preço %
Cupom %
Data de vencimento
Montante em circulação
Valor de face
Valor mín. de denominação
Emissor
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,00%26 K76,04%4,750%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,57%100 K80,26%4,625%2042-10-0167,49 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,53%24 K82,04%4,850%2044-06-1565,23 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,49%26 K90,47%3,200%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,37%9,72 M102,10%5,500%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,30%22 K94,50%4,550%2035-03-15107,65 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,27%4,87 M101,81%5,400%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,27%7,91 M104,87%5,600%2055-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,26%7,6 M86,27%4,250%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,24%16 K95,15%4,875%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4241924AbbVie Inc. 4.7% 14-MAY-2045
5,21%4,89 M93,71%4,700%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4362396AbbVie Inc. 4.45% 14-MAY-2046
5,21%154 K90,48%4,450%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,20%1,45 M94,48%4,750%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,19%1 M95,95%4,850%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,17%50 K102,05%5,350%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,10%791 K92,03%4,400%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,09%670 K94,77%4,625%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
4,93%190 K91,15%4,050%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4,65%097,06%4,300%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4,60%099,21%4,500%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,58%76 K104,71%5,200%2035-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,54%2,43 M100,08%4,550%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,46%11,49 M104,04%5,050%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,09%177 K104,09%4,950%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
4,06%099,55%3,200%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
3,99%4,76 M97,05%3,200%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
3,97%440 K103,59%4,875%2030-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AA19H80Allergan Funding SCS 2.125% 01-JUN-20293,91%094,11%2,125%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3,91%545 K102,80%4,800%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,90%200 K101,22%4,800%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,86%721 K99,06%2,950%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3,85%1,15 M101,14%4,250%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3,84%5,03 M101,83%4,650%2028-03-151,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
3,38%097,86%2,625%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,16%0126,76%4,750%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3,13%0128,71%4,850%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,13%0121,31%4,250%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
2,73%091,83%1,250%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,57%0123,74%4,550%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2,51%098,70%2,125%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2,45%0100,52%2,625%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2,40%099,21%2,125%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2,21%097,09%0,750%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5,92%0111,17%2,950%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,400%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.